Etoricoxib
Back to searchMolecule Structure
Scientific Name
Etoricoxib
Description of the Drug
Etoricoxib is a selective COX-2 inhibitor used to relieve moderate post-surgical dental pain as a short-term treatment and inflammatory and painful symptoms of various forms of arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01628
http://www.drugbank.ca/drugs/DB01628
Brand Name(s)
Arcoxia
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cyclooxygenase-2 | SINGLE PROTEIN | INHIBITOR | CHEMBL230 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4680 |
| PharmGKB | PA164776853 |
| Human Metabolome Database | HMDB0015565 |
| DrugBank | DB01628 |
| PubChem: Thomson Pharma | 14828179 |
| PubChem | 123619 |
| Mcule | MCULE-9552824917 |
| LINCS | LSM-5650 |
| Nikkaji | J1.126.176K |
| PDBe | 5CH |
| BindingDB | 50072064 |
| EPA CompTox Dashboard | DTXSID3046457 |
| DrugCentral | 1113 |
| Brenda | 143395 |
| ChemicalBook | CB0223494 |
| Guide to Pharmacology | 2896 |
| rxnorm | ETORICOXIB |
| PubChem: Drugs of the Future | 12015199 |
| KEGG Ligand | C11718 |
| ChEBI | 6339 |
| ZINC | ZINC000000579472 |
